MATERIAL AND METHODS
Now a day’s anti-resorptive and anabolic agents are mainly used to treat osteoporosis. We performed a clinical research investigation and determine the effectiveness of recombinant PTH i.e. parathyroid hormone versus bisphosphonates for the treatment of osteoporosis. The study is aimed to assess the efficacy of recombinant parathyroid hormone versus bisphosphonates for treating osteoporosis on Visual Analogue Scale (VAS).